Antibiotic Resistance Market Players, Size, Share, Research Report- Forecast till 2030

Antibiotic Resistance Market

Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs. Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.

Antibiotic resistance market is expected to reach USD 17387.01 million at CAGR of 5.34% during the forecast period of 2020 to 2030

The growth of global antibiotic resistance market is driven by various factors such as -      Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance

Several market players currently dominate the global antibiotic resistance market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the Key Antibiotic Resistance Market Players are Achaogen, Inc. (US), MELINTA THERAPEUTICS, INC. (US), Nabriva Therapeutics plc (Ireland), PARATEK therapeutics (US), Seres Therapeutics (US), Theravance Biopharma (UK), Tetraphase Pharmaceuticals (US), Basilea Pharmaceutica Ltd. (Switzerland), Entasis Therapeutics (US), NEMESIS BIOSCIENCE LTD (UK), Procarta Biosystems (England), and Allecra Therapeutics (US)

Segment Analysis

The Global Antibiotic Resistance Market has been Segmented Based on Drug Class, Disease, Pathogen, and End User.

The market, based on drug class, has been divided into cephalosporins, Combination therapies, tetracyclines, lipoglycopeptides, oxazolidinones, and others. The combination therapies segment is likely to be the largest growth during the review period due to the increased usage of these therapies for gram-negative infections. Additionally, it has minimal treatment options available with the increasing demand for antibiotic resistance, thus driving the growth of this segment.

The global antibiotic resistance market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others. The complicated urinary tract infections segment is expected to hold the majority share of the market as urinary tract infections (UTIs) are one of the most common types of infections. Additionally, there were around 1,045 patients affected by UTI.

The global antibiotic resistance market has been segmented based on pathogen into staphylococcus aureus, streptococcus pneumoniae, antibiotic resistant bacteria, acinetobacter, enterococcus, Hemophilus influenzae, pseudomonas aeruginosa, clostridium difficile, K. pneumoniae, campylobacter, and others. K. pneumoniae is expected to be the fastest segment owing to the increasing K. pneumoniae. Moreover, there were around 212,500 infection cases per year and about 70 deaths every year which would eventually drive the growth of the antibiotic market in this segment.

The end user segment of the antibiotic resistance market includes hospitals & clinics, research organizations, and others. The hospitals & clinics segment is expected to hold the largest share of the market as the majority of treatments and procedures are carried out in hospitals, which ultimately increases the usage of antibiotic resistance drugs in the antibiotic resistance market. As a result, this drives the growth of the antibiotic resistance market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector. The antibiotic resistance market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European antibiotic resistance market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The antibiotic resistance market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing healthcare expenditure has boosted the growth of the antibiotic resistance market; the market in Asia-Pacific is expected to be the fastest-growing. The antibiotic resistance market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Serotonin Syndrome Market, Size, Share, Growth, Business Risk & Industry Analysis Reports 2030

  Serotonin Syndrome Market The serotonin syndrome market report is an informative and in-depth analysis that offers a detailed overview of the industry, including recent developments and potential proportions of the demand for serotonin syndrome in terms of products and services.  The  Serotonin Syndrome Market  is expected to reach USD 692.2 Million by 2030 at 4.8% CAGR during the forecast period 2022-2030. Serotonin syndrome is a group of symptoms such as high body temperature, increased reflexes, anxiety, tremor, sweating, diarrhea, dilated pupils, etc. due to the use of serotonergic drugs. Severe complications, such as seizures and extensive muscle breakdown, can lead to death. The case of Libby Zion in 1984 is an example of death from serotonin syndrome. Serotonin syndrome is usually caused by a synergistic effect of two or more serotonergic drugs, commonly including serotonin norepinephrine reuptake inhibitor (SNRI), selective serotonin reuptake inhibitor (SSR...
Read more

Personalized Medicine Market, Opportunities, Size, Share, Trends Analysis and Forecast to 2032

  By 2032, the personalized medicine market is expected to be worth USD 970.7 billion, growing at a CAGR of 7.20%. The global demand for novel drugs to treat the rising incidence of cancer and other diseases is one of the factorersonalized medicine, also identifies patients who will likely benefit from specific therapy and supports long-term monitoring of how they react to that treatment. Physicians can make better choices about the most suitable treatments for their patients via companion diagnostics, and they can modify those treatments, if necessary, based on each patient's unique response, driving the development of personalized medicine market growth. Additionally, companion tests specifically created to assess a subject's suitability for a given treatment and their reaction to a prescribed course of treatment increasingly use personalized medicine in their applications. In contrast to the conventional "one size fits all" approach, personalized medicine posses...
Read more

Electric Wheelchair Market Global Synopsis, Future Scope, Top Key Players and Forecast to 2030

  Electric Wheelchair Market Electric wheelchairs get power from an electric motor that comes attached with the electric wheelchair. These wheelchairs offer great mobility and are light in weight. These are very compact in size and can be used in narrow pathways. The global electric wheelchair market is expecting substantial market growth during the forecast period (2019-2023). Market Research Future (MRFR) made a claim recently that the global electric wheelchair market can surpass the existing market valuation with relative ease. Electric Wheelchair Market  size is expected to reach USD 6.47 Billion by 2030 at 6.8% CAGR during the forecast period 2022-2030. The electric wheelchair market is expecting strong support from various pointers for a better market growth. It is expecting strong growth due to competitors participating more and more in the market to take the market ahead with their strategic moves. Its easy application is fast gaining momentum. Latest innovations are ...
Read more